These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 15631354
21. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT, Fu L, Xia JC, Feng BJ, Mai SJ, Yu XJ, Huang LX, Feng QS, Pan ZZ, Zhan YQ. Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [Abstract] [Full Text] [Related]
22. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Miyai K, Furugen Y, Matsumoto T, Iwabuchi K, Hirose S, Kinoshita K, Fujii H. Gynecol Oncol; 2004 Jul; 94(1):115-20. PubMed ID: 15262128 [Abstract] [Full Text] [Related]
23. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder. Erbersdobler A, Friedrich MG, Schwaibold H, Henke RP, Huland H. Oncol Res; 1998 Jul; 10(8):415-20. PubMed ID: 10100758 [Abstract] [Full Text] [Related]
25. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study. Gomes CC, Fonseca-Silva T, Gomez RS. Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918 [Abstract] [Full Text] [Related]
27. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium. Clin Cancer Res; 2003 Oct 01; 9(12):4435-42. PubMed ID: 14555516 [Abstract] [Full Text] [Related]
29. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder. Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM. Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332 [Abstract] [Full Text] [Related]
31. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer. Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J. Anticancer Res; 2004 Dec 14; 24(6):4259-63. PubMed ID: 15736482 [Abstract] [Full Text] [Related]
37. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Watson RH, Neville PJ, Roy WJ, Hitchcock A, Campbell IG. Oncogene; 1998 Jul 16; 17(2):207-12. PubMed ID: 9674705 [Abstract] [Full Text] [Related]
38. [Analysis of genetic instabilities on chromosome loci 3, 6, 11, and 18 in human cervical carcinoma]. Zhao M, Wu XX. Ai Zheng; 2002 Jun 16; 21(6):640-3. PubMed ID: 12452066 [Abstract] [Full Text] [Related]
39. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer. Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT. Cancer; 2005 Nov 01; 104(9):1918-23. PubMed ID: 16149093 [Abstract] [Full Text] [Related]
40. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L. Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]